40 cases on record
- Cases on record
- 40
- As claimant
- 2
- As respondent
- 38
- Patents held
- Not recorded
- Core tech
- Not recorded
| Case no. | Parties | Role | Court | Filed | Duration | Outcome |
|---|---|---|---|---|---|---|
| 1:26-cv-01730 | Novo Nordisk A/S v. Apotex, Inc. | Defendant | D.N.J. | 20 Feb 2026 | 10 d | Closed |
| 1:25-cv-01488 | Actelion Pharmaceuticals US, Inc. v. Apotex, Inc. | Defendant | D. Del. | 10 Dec 2025 | 127 d | Consent Judgment |
| 1:25-cv-01086 | Alkermes, Inc. v. Apotex, Inc. | Defendant | D. Del. | 28 Aug 2025 | 67 d | Voluntary dismissal |
| 2:25-cv-12184 | Supernus Pharmaceuticals, Inc. v. Apotex, Inc. | Defendant | D.N.J. | 26 Jun 2025 | 180 d | Case Consolidated |
| 1:25-cv-00775 | Pfizer, Inc. v. Apotex, Inc. | Defendant | D. Del. | 23 Jun 2025 | 119 d | Dismissed without Prejudice |
| 1:25-cv-00765 | Pfizer, Inc. v. Apotex, Inc. | Defendant | D. Del. | 20 Jun 2025 | 42 d | Dismissed without Prejudice |
| 1:25-cv-00694 | Bayer AG v. Apotex, Inc. | Defendant | D. Del. | 5 Jun 2025 | 187 d | Voluntary dismissal |
| 1:25-cv-04044 | Incyte Corp. v. Apotex, Inc. | Defendant | D.N.J. | 8 May 2025 | 188 d | Case Consolidated |
| 1:25-cv-00211 | Vifor (International), AG v. Apotex, Inc. | Defendant | D. Del. | 20 Feb 2025 | 480 d | Dismissed without Prejudice |
| 1:24-cv-01004 | Otsuka Pharmaceutical Co., Ltd. v. Apotex, Inc. | Defendant | D. Del. | 30 Aug 2024 | 593 d | Dismissed without Prejudice |
| 1:24-cv-00818 | Bristol-Myers Squibb v. Apotex, Inc. | Defendant | D. Del. | 15 Jul 2024 | 485 d | Case Dismissed |
| 2:24-cv-07550 | Jazz Pharmaceuticals Research UK Limited v. Apotex, Inc. | Defendant | D.N.J. | 3 Jul 2024 | 69 d | Dismissed without Prejudice |
| 1:24-cv-00577 | Apotex, Inc. v. Boehringer-Ingelheim | Plaintiff | D. Del. | 13 May 2024 | 291 d | Judgment on the merits for Plaintiff |
| 1:24-cv-00551 | AstraZeneca AB v. Apotex, Inc. | Defendant | D. Del. | 6 May 2024 | 449 d | Dismissed without Prejudice |
| 1:24-cv-00327 | American Regent, Inc. v. Apotex, Inc. | Defendant | D. Del. | 13 Mar 2024 | 128 d | Voluntary dismissal |
| 2:24-cv-02268 | American Regent, Inc. v. Apotex, Inc. | Defendant | D.N.J. | 11 Mar 2024 | 114 d | Case Consolidated |
| 2:23-cv-23141 | Jazz Pharmaceuticals Research UK Limited v. Apotex, Inc. | Defendant | D.N.J. | 15 Dec 2023 | 270 d | Dismissed without Prejudice |
| 2:23-cv-03860 | Oyster Point Pharma, Inc. v. Apotex, Inc. | Defendant | D.N.J. | 19 Jul 2023 | 799 d | Consent Judgment |
| 1:23-cv-00774 | Gilead Sciences, Inc. v. Apotex, Inc. | Defendant | D. Del. | 14 Jul 2023 | 585 d | Case Consolidated |
| 1:23-cv-00775 | Gilead Sciences, Inc. v. Apotex, Inc. | Defendant | D. Del. | 14 Jul 2023 | 647 d | Consent Judgment |
| 1:23-cv-00734 | Actelion Pharmaceuticals, Ltd. v. Apotex, Inc. | Defendant | D. Del. | 6 Jul 2023 | 84 d | Consent Judgment |
| 1:23-cv-00710 | Otsuka Pharmaceutical Co., Ltd. v. Apotex, Inc. | Defendant | D. Del. | 30 Jun 2023 | 89 d | Consent Judgment |
| 1:23-cv-00704 | Apotex, Inc. v. Boehringer lngelheim Pharmaceuticals, Inc. | Plaintiff | D. Del. | 28 Jun 2023 | 104 d | Judgment on the merits for Plaintiff |
| 1:23-cv-00655 | Merck KGaA v. Apotex, Inc. | Defendant | D. Del. | 15 Jun 2023 | 963 d | Closed |
| 1:23-cv-00445 | Pfizer, Inc. v. Apotex, Inc. | Defendant | D. Del. | 21 Apr 2023 | 41 d | Voluntary dismissal |
| 1:23-cv-00327 | Bayer AG v. Apotex, Inc. | Defendant | D. Del. | 24 Mar 2023 | 340 d | Dismissed with Prejudice |
| 0:22-cv-62432 | Vanda Pharmaceuticals, Inc. v. Apotex, Inc. | Defendant | S.D. Fla. | 28 Dec 2022 | 84 d | Voluntary dismissal |
| 2:22-cv-07529 | Vanda Pharmaceuticals, Inc. v. Apotex, Inc. | Defendant | D.N.J. | 27 Dec 2022 | 45 d | Case Transferred |
| 1:22-cv-01596 | Bayer AG v. Apotex, Inc. | Defendant | D. Del. | 14 Dec 2022 | 1112 d | Dismissed with Prejudice |
| A-244-22 | Eli Lilly Canada Inc. v. Apotex, Inc. | Defendant | Canada Federal Court of Appeal | 16 Nov 2022 | 517 d | Appeal Dismissed |
| 1:22-cv-01399 | Gilead Sciences, Inc. v. Apotex, Inc. | Defendant | D. Del. | 25 Oct 2022 | 847 d | Case Consolidated |
| 1:22-cv-01400 | Gilead Sciences, Inc. v. Apotex, Inc. | Defendant | D. Del. | 25 Oct 2022 | 300 d | Dismissed without Prejudice |
| 1:22-cv-01232 | Zogenix, Inc. v. Apotex, Inc. | Defendant | D. Del. | 21 Sep 2022 | 433 d | Case Dismissed in Part |
| 3:22-cv-03827 | Amgen, Inc. v. Apotex, Inc. | Defendant | D.N.J. | 14 Jun 2022 | 224 d | Consent Judgment |
| 1:22-cv-00640 | Horizon Medicines, LLC v. Apotex, Inc. | Defendant | D. Del. | 13 May 2022 | 350 d | Consent Judgment |
| 1:21-cv-01533 | Zogenix, Inc. v. Apotex, Inc. | Defendant | D. Del. | 28 Oct 2021 | 761 d | Case Consolidated |
| 1:21-cv-01252 | Zogenix, Inc. v. Apotex, Inc. | Defendant | D. Del. | 30 Aug 2021 | 820 d | Consent Judgment |
| 1:20-cv-01105 | Intercept Pharmaceuticals, Inc. v. Apotex, Inc. | Defendant | D. Del. | 21 Aug 2020 | 917 d | Consent Judgment |
| A-234-20|A-236-20|A-237-20|A-238-20 | Eli Lilly Canada Inc. v. Apotex, Inc. | Defendant | Canada Federal Court of Appeal | – | Patent Invalidated | |
| T-1121-22|T-1122-22|T-1248-22|T-1249-22 | Janssen Inc. v. Apotex, Inc. | Defendant | Canada Federal court | – | Case Dismissed |
Source: Patsnap Litigation Data. Cases naming Apotex, Inc. in the current snapshot.
Run this in Eureka
Patsnap Eureka
See what Apotex is protecting
Portfolio, claim scope and where its coverage is thin. Every answer cites the records behind it.
Analyse this portfolio10,000 free credits to start
Apotex
Map this dispute space
- 01Ranked prior artEvery hit source-linked
- 02Claim-level comparisonAgainst your own product
- 03Legal statusAcross 174 jurisdictions
Disclaimer. This page indexes publicly available court docket data and is provided for general information and reference only. It is not legal advice and must not be relied upon as such.
Coverage has limits. Records come from a snapshot and may lag live dockets. Sealed filings, amended complaints and post-closure motions may not be reflected, and a case missing from this list is not evidence that it does not exist. Counts on this page describe what the snapshot contains, nothing more.
No characterisation of any party. Appearing on this page means a party is named in a docket record. Nothing here should be read as an assertion that any party infringed, that any patent is valid or invalid, or that any party prevailed.